MedTech Acquisition Corporation (MTAC) Research
MedTech Acquisition Corporation currently has no significant active business operations. The firm's stated intention is to pursue and finalize a business combination — which could involve a merger, stock exchange, asset acquisition, or other forms of corporate restructuring — with one or more enterprises in the U.S. healthcare industry. Established in 2020, its corporate base is situated in Greenwich, Connecticut.
Market snapshot
- Symbol
- MTAC
- Price
- $11.34
- Day change
- +18.67%
- Market cap
- $154.7M
- P/E ratio
- -7.70x
- 52-week range
- 8.43-12.8299
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
Recent insider activity
- Devlin Jodi — A-Award (195000 shares) on 2023-08-30
- Devlin Jodi — trade (0 shares) on 2023-08-28
- Szela Mary T — A-Award (172500 shares) on 2023-08-14
- Szela Mary T — trade (0 shares) on 2023-08-10
- Szela Mary T — trade (177973 shares) on 2023-08-10
Open MedTech Acquisition Corporation (MTAC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.